Studi Clinici aperti all’arruolamento

ARISE – “Acalabrutinib Real world Italian obSErvational study-ITALIAN MULTICENTRIC OBSERVATIONAL SECONDARY DATA COLLECTION STUDY OF ACALABRUTINIB IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA”

Catanzaro – AOU Renato Dulbecco – Presidio Mater Domini
Principal Investigator: Prof. Daniele Caracciolo
Per informazioni sull’arruolamento contattare:  clinicaltrials.oncology@unicz.it (Tel: 0961-3647921)

 

 

GIMEMA CLL2423 – Incidence of severe COVID-19 infection in patients with chronic lymphocytic leukemia or indolent B-cell non-Hodgkin lymphoma who received pre-exposure prophylaxis with Tixagevimab and Cilgavimab in Italy: an observational study by the GIMEMA Working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi.

Catanzaro – AOU Renato Dulbecco – Presidio Mater Domini
Principal Investigator: Prof. Daniele Caracciolo
Per informazioni sull’arruolamento contattare:  clinicaltrials.oncology@unicz.it (Tel: 0961-3647921)